Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
暂无分享,去创建一个
Tohru Suzuki | Tohru Suzuki | M. Kiso | H. Ishida | Makoto Kiso | Hideharu Ishida | Sadagopan Magesh | Setsuko Moriya | Taeko Miyagi | T. Miyagi | S. Moriya | S. Magesh
[1] K. Yamaguchi,et al. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] K. Yamaguchi,et al. Down‐regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers , 2007, Cancer science.
[3] G. Borsani,et al. Recent Development in Mammalian Sialidase Molecular Biology , 2002, Neurochemical Research.
[4] T. Irimura,et al. Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification. , 2006, Oncology research.
[5] K. Yamaguchi,et al. Evidence for mitochondrial localization of a novel human sialidase (NEU4). , 2005, The Biochemical journal.
[6] E. Monti,et al. Expression of Sialidase Neu2 in Leukemic K562 Cells Induces Apoptosis by Impairing Bcr-Abl/Src Kinases Signaling* , 2007, Journal of Biological Chemistry.
[7] K. Yamaguchi,et al. Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility* , 2006, Journal of Biological Chemistry.
[8] Komandoor E. Achyuthan,et al. Comparative enzymology, biochemistry and pathophysiology of human exo-α-sialidases (neuraminidases) , 2001 .
[9] Taeko Miyagi,et al. Aberrant Expression of Sialidase in Cancer , 2004 .
[10] C. Venkatachalam,et al. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. , 2003, Journal of molecular graphics & modelling.
[11] K. Koseki,et al. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells , 2007, Oncogene.
[12] Soichi Wakatsuki,et al. Crystal Structure of the Human Cytosolic Sialidase Neu2 , 2005, Journal of Biological Chemistry.
[13] P. Alzari,et al. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase. , 2007, Bioorganic & medicinal chemistry.
[14] Keiko Hata,et al. Sialidase and malignancy: A minireview , 2003, Glycoconjugate Journal.
[15] Tohru Suzuki,et al. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors. , 2006, Journal of molecular graphics & modelling.
[16] M. Obinata,et al. Overexpression of Plasma Membrane-associated Sialidase Attenuates Insulin Signaling in Transgenic Mice* , 2003, Journal of Biological Chemistry.
[17] C. Schengrund,et al. Biological Roles of Sialic Acid , 1976, Springer US.
[18] D. M. Ryan,et al. Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.
[19] J. C. Dyason,et al. Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase. , 2006, Bioorganic & medicinal chemistry.